Login / Signup

Treatment of resectable intrathoracic sarcomas: a single institution experience over twenty years.

David RaineyJacob BerriochoaAnna KorpakJing ZengElizabeth T LoggersRobin L JonesShilpen Patel
Published in: Journal of radiation oncology (2015)
Our series is the largest published study of intrathoracic sarcoma which focuses on the survival benefit of adding RT, chemotherapy or both to surgery in resectable intrathoracic sarcoma. Our data suggest a potential benefit in local control and survival from adjuvant therapy, with the greatest benefit likely to come from combined CT and RT, though none of the results achieved statistical significance. As intrathoracic sarcomas are rare and histologically heterogeneous, larger collaborative studies are necessary to determine treatment efficacy and elucidate which histologic subtypes are likely to benefit most from adjuvant therapy.
Keyphrases